Virta Health, a San Francisco, CA-based company dedicated to reversing type 2 diabetes without medications or surgery, raised $65m in Series D funding.
The round, which brought total funding to more than $230m and valued Virta Health at over $1.1 billion, was led by Sequoia Capital Global Equities with participation from Caffeinated Capital.
The company intends to use the funds to accelerate investments in growth, scale its provider-led virtual care delivery platform, Continuous Remote Care, and expand research and development of evidence-based, non-pharmaceutical therapies for other complex and costly metabolic conditions.
Led by Sami Inkinen, co-founder and CEO, Virta Health provides a treatment to reverse type 2 diabetes without medications or surgery delivered through its novel continuous remote care platform.
FinSMEs
02/12/2020